Pilot Study of Whole Blood Transfusion for Trauma Brain Injury (TBI)

Oregon Health & Science University (OHSU)

Status and phase: Not yet enrolling; Phase 3

Conditions: Traumatic Brain Injury

Treatments: Biological: Whole blood transfusion; Biological: Blood components transfusion

Study type: Interventional

Funder types: Other

Identifiers

NCT06184828

25989

Details and patient eligibility

About

Our goal is to perform a pilot, single center study to evaluate the efficacy of whole blood (WB) in subjects with TBI, intracranial hemorrhage, and anemia compared to blood component therapy.

Full description

Both whole blood and blood components are given as standard-of-care based on the blood products available. If enrolled in this study, patients will be randomized 1:1 to receive either whole blood or blood components first. They will continue to receive blood products based on their assigned group. If they require more blood product than is available, they will cross over to the other group so they can continue to receive the transfusions needed for treatment.

The primary endpoint for this study would be improvement in coagulopathy pre and post intervention. Additionally, we will evaluate hemorrhagic progression of the intracranial bleed (HPIB), as measured by follow-up CT scan ordered over the first 24-hour post intervention (which is standard of care).

The secondary outcomes parameters would include intracranial pressure measurements (if performed), survival to discharge, safety and tolerability of Whole Blood administration in the TBI population, coagulation parameters and total blood product use, Glasgow Coma Scale (GCS) 24 hours post-injury, in-hospital mortality, and patient's discharge status (Glasgow Outcome Score Extended and disposition to home versus extended care facility).

Patients who decide to take part in the study, will have 26 mL of blood drawn (about 2 tablespoons) once before and once after blood transfusion for a total of 52 mL (about 4 tablespoons) of blood drawn, a CT scan at admission and at 24hour of blood transfusion, and information will be gathered from their medical record during their hospital stay.

Enrollment: 100 estimated patients

Sex: All

Ages: 15 to 120 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 15 years and older
• Head CT with presence of intracranial bleeding
• Required transfusion of whole blood (WB) or red blood cells (RBC)

Exclusion criteria

• Patients with non-survivable injuries (expected to die within 24-hours of injury)
• Fixed and dilated pupils
• Patients requiring a massive transfusion protocol activation
• Receipt of 2 units of WB or RBCs prior to enrollment
• Known prisoners
• Known pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Whole Blood Transfusion

Experimental group

Description:

Transfusion of whole blood units

Treatment:

Biological: Whole blood transfusion

Blood Component Transfusion

Active Comparator group

Description:

Transfusion of blood components units

Treatment:

Biological: Blood components transfusion